Collagenase 3 (Matrix Metalloproteinase 13 or MMP13 or EC 3.4.24.) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update

Published	Pages	Publisher	Report code
Aug 2022	54	Global Markets Direct	ASDR-609058

Published: Aug 2022 - Pages : 54 - Publisher : Global Markets Direct - Report code : ASDR-609058

Aquilus Pharmaceuticals Inc
Avantyx Pharmaceuticals LLC
Paradigm Biopharmaceuticals Ltd
Pharmahungary Group
SteroTherapeutics LLC

Published: February, 2020 | Report code: ASDR-513655

09 September - 10 September, 2024
London, United Kingdom